Ethocybin

Ethocybin
Clinical data
Other names	4-Phosphoryloxy-N,N-diethyltryptamine; CEY-19; 4-phosphoryloxy-DET; 4-PO-DET
Routes of; administration	Oral
Drug class	Serotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code	None;
Legal status
Legal status	DE: Anlage I (Authorized scientific use only); UK: Class A;
Pharmacokinetic data
Duration of action	2–6 hours
Identifiers
	IUPAC name Phosphoric acid mono-[3-(2-diethylamino-ethyl)-1H-indol-4-yl] ester;
CAS Number	60480-02-6 ;
PubChem CID	53633102;
ChemSpider	21106438 ;
UNII	Z47K2YT973;
CompTox Dashboard (EPA)	DTXSID80705541 ;
Chemical and physical data
Formula	C14H21N2O4P
Molar mass	312.306 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN(CC)CCC2=CNC1=CC=CC(OP(O)(O)=O)=C12;
	InChI InChI=1S/C14H21N2O4P/c1-3-16(4-2)9-8-11-10-15-12-6-5-7-13(14(11)12)20-21(17,18)19/h5-7,10,15H,3-4,8-9H2,1-2H3,(H2,17,18,19) ; Key:AAVKQQUBPHSCML-UHFFFAOYSA-N ;
	(verify)

Ethocybin also known as 4-phosphoryloxy-N,N-diethyltryptamine (4-PO-DET) or as CEY-19, is a psychedelic drug of the tryptamine and 4-hydroxytryptamine families related to the psilocybin-containing mushroom alkaloid psilocybin. It is assumed to act as a prodrug of 4-HO-DET (CZ-74) analogously to how psilocybin (4-PO-DMT) acts as a prodrug of psilocin (4-HO-DMT). The drug was first described in the literature by Albert Hofmann and colleagues at Sandoz by 1963.